Patients who need PCSK9 inhibitors can’t get them April 29, 2017By Tracey WalkerStudy: PCSK9 inhibitors are being rejected by insurers at very high rates even in high-risk patients like those with familial hypercholesterolemia. Researchers identify more effective, cost-efficient test for breast cancer risk April 25, 2017By Tracey WalkerNew findings reveal this genetic test to assess breast cancer risk could be more effective than others. ACA uncertainty impacts rate of insured: What health execs should know April 22, 2017By Tracey WalkerA Gallup-Healthways poll shows it will be important to monitor the uninsured trends in the coming months as the ACA hangs in the balance. How to connect with the sickest, neediest patients April 21, 2017By Tracey WalkerA new Commonwealth Fund survey on how Medicaid changes could affect this population, has experts weighing in on ways to resolve the healthcare disconnect. Zika vaccine progress: Five things to know April 20, 2017By Karen AppoldTo date, the CDC reports 5,234 Zika virus disease cases in the United States and 36,526 cases in U.S. territories. Here’s where we are in the vaccine development process. How to make health price information more accessible to consumers April 19, 2017By Tracey WalkerNational survey and surveys in New York State, Florida, Texas, and New Hampshire point to a need for more actionable price information. How one hospital reduced pediatric epilepsy emergency visits, admissions April 18, 2017By Tracey WalkerNationwide Children’s Hospital sees dramatic drop in ED visits and inpatient admissions for epilepsy patients with collaborative quality improvement project. Pop health project finds new ties between health, finances, location April 17, 2017By Donna MarburyPopulation health data strategies are finding connections between better health and better quality of living. Hospital pop health program increases cancer screenings, patient engagement April 17, 2017By Donna MarburyA hospital system is adapting population health data to create a blueprint for a cost savings patient care program. Game-changing cholesterol-buster further reduces heart attack, stroke April 16, 2017By Tracey WalkerA new outcomes study shows that the PCSK9 inhibitor Repatha significantly reduced the risk of hard major adverse cardiovascular events in high-risk patients by 20%.